Allogene Therapeutics (ALLO) P/E (2018 - 2026)
Allogene Therapeutics (ALLO) P/E from Oct 11, 2018 to Jul 21, 2026. The TTM Allogene Therapeutics (ALLO) P/E is -2.43. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Allogene Therapeutics (ALLO)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.43 | +52.66% |
| 2025 | -1.59 | -2.87% |
| 2024 | -1.64 | +14.59% |
| 2023 | -1.43 | -62.35% |
| 2022 | -3.80 | -67.34% |
| 2021 | -11.65 | -15.33% |
| 2020 | -13.76 | -20.24% |
| 2019 | -17.25 | -77.57% |
| 2018 | -76.90 | N/A |
Comparison Allogene Therapeutics (ALLO) P/E with competitors
Allogene Therapeutics (ALLO) P/E is -2.43.